Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WO4T
|
|||
| Drug Name |
PMID27998201-Compound-24
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Glioma [ICD-11: 2A00.0; ICD-9: 191] | Patented | [1] | |
| Meningioma tumour [ICD-11: 2A01] | Patented | [1] | ||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H32
|
|||
| Canonical SMILES |
CC(C)C1=CCC2=C(C1)CCC3C2(CCCC3(C)C)C
|
|||
| InChI |
1S/C20H32/c1-14(2)15-7-9-17-16(13-15)8-10-18-19(3,4)11-6-12-20(17,18)5/h7,14,18H,6,8-13H2,1-5H3/t18?,20-/m1/s1
|
|||
| InChIKey |
BGVUIJDZTQIJIO-ROPPNANJSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cathepsin B (CTSB) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Cathepsin B (CTSB) | Target's Patent Info | [1] | |
| KEGG Pathway | Lysosome | |||
| Antigen processing and presentation | ||||
| NetPath Pathway | TCR Signaling Pathway | |||
| IL2 Signaling Pathway | ||||
| Reactome | Collagen degradation | |||
| Trafficking and processing of endosomal TLR | ||||
| Assembly of collagen fibrils and other multimeric structures | ||||
| MHC class II antigen presentation | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cathepsin B and L inhibitors: a patent review (2010 - present).Expert Opin Ther Pat. 2017 Jun;27(6):643-656. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.